Back to Annual Meeting
Back to Annual Meeting
|
Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
3277.0: Monday, November 05, 2007: 2:30 PM-3:30 PM | ||||
Poster | ||||
| ||||
| The development and implementation of antiretrovial therapy has had a major impact regarding the number of HIV/AIDS deaths. In general, the focus of the posters herein is to increase our understanding of issues surrounding medical management of HIV/AIDS among underserved populations. Topics covered in this session include the following: (1) impact of race/ethnicity on attitudes towards antiretrovial therapy and adherence; (2) understanding the possible medical complications (e.g., anemia) and the implications of such among persons residing in resource poor countries; (3) relationship of medical adherence to socio-demographic variables, stress, coping behaviors, and risk behaviors; (4) examining these issues specific to persons with a mental health illness, and (5) increasing our knowledge base regarding the pathogenesis of HIV and the decline in CD4 T cells. | ||||
| Learning Objectives: 1. Identify factors associated with HIV medication adherence among diverse, vulnerable, underserved groups 2. Discuss issues surrounding the medical management of HIV. 3. Describe possible adverse outcomes associated with antiretrovial treatments. | ||||
| Moderator(s): | Karen Gibson, BA | |||
| Board 1 | Discrimination, Distrust, and Racial/Ethnic Disparities in Antiretroviral Therapy Adherence by HIV+ Patients Angela Thrasher, PhD, MPH, Jo Anne Earp, ScD, Catherine Zimmer, PhD, Carol Golin, MD | |||
| Board 2 | Comparison study on the development of severe anemia as a side effect from two most commonly used HAART regimens in HIV/AIDS patients at Patna, India Diwakar Tejaswi, PhD | |||
| Board 3 | Adherence in the medical management of HIV/AIDS: Stress and coping William Q. Hua, BS, Mark A. Vosvick, PhD, Chwee-Lye Chng, PhD | |||
| Board 4 | How does HIV status affect rates of psychotropic use by Medicaid patients with schizophrenia? James Walkup, PhD, Scott M. Bilder, MS, Stephen Crystal, PhD | |||
| Board 5 | An Integrated Approach to ARV Delivery: IPPF's experience in the Dominican Republic Jessica Halverson, MPH, LMSW, Jane Galvao, PhD, Magaly Caram, PhD, Aleisha Rozario, MPH student | |||
| Board 6 | Antiretroviral drug resistance among treatment-naïve HIV-1 infected individuals in Washington, DC Nicole A. Lamparello, Emily M. Herzberg, Allison C. Boyd, Mariah M. Marshall, Miguel A. DeLeon, Allison Porter, Debra Dekker, PhD, Charles H. Evans, MD, PhD, Michael Relf, PhD, RN | |||
| Board 7 | Cognitive Executive Functioning in Relation to HIV Medication Adherence among Gay, Bisexual, and Other Men who Have Sex with Men Todd M. Solomon, BS, Perry N. Halkitis, PhD | |||
| Board 8 |  | Factors affecting HIV therapy adherence amongst marginalized urban men who have sex with men (MSM) Jason Gagnon, MPH, MA, Seth Welles, ScD, PhD, Anthony Japour, MD | ||
| Board 9 | Role of Retinoids in the Pathogenesis and Treatment of HIV infection: Hypothesis Anthony R. Mawson, MA, DrPH, Sridevi Alla, MBBS | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | ||||
| Organized by: | HIV/AIDS | |||
| Endorsed by: | Socialist Caucus | |||
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA